Leucotrichia in Vitiligo

Leucotrichia Clinical Trial

Official title:

Leucotrichia in Vitiligo Patients : A Cross Sectional Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03402633
• Other study ID #: Dermatology5
• Status: Completed
• Phase: N/A
• First received: January 11, 2018
• Last updated: January 11, 2018
• Start date: April 2016
• Est. completion date: September 2016

Study information

• Verified date: January 2018
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The incidence of leucotrichia has been reported to range from 9 to 48.4% of all vitiligo patients.Leucotrichia is more often observed in segmental vitiligo with a very high percentage. However, further studies considering the prevalence of leucotrichia in different types of vitiligo need to be conducted.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 107
• Est. completion date: September 2016
• Est. primary completion date: September 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age > 18

• Vitiligo patients with/ without leukotrichia within the vitiliginous areas

Exclusion criteria:

• Age < 18

• Premature hair graying in the trunk before the age of 30

Related Conditions & MeSH terms

• Leucotrichia
• Vitiligo

Intervention

Other:
• Examination of leukotrichia in vitiligo patients
Examination of leukotrichia will be enhanced by wood's light and dermoscopy for better enhancing of the lesions and good magnification

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Detection of prevalence of leukotrichia within vitilignous areas in vitiligo patients	Detection of prevalence of leukotrichia within vitilignous areas in vitiligo patients	within 6 months